Gollob Jared's Form 4 filing
Kymera Therapeutics, Inc. (KYMR) · filed Nov 2, 2021
- Accession no.
- 0000899243-21-042437
- Filed
- Nov 2, 2021
- Trade date
- Nov 1-2, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 10 non-derivative transactions and 3 derivative transactions. Open-market sales total $3.57M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gollob JaredCIK 0001821198 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 1, 2021 | Common Stock | MOption exerciseAcquired | +20,000 | $1.31 | +$26,200 | 62,547 | Direct | |
| Nov 1, 2021 | Common Stock | MOption exerciseAcquired | +4,607 | $2.08 | +$9,582.56 | 67,154 | Direct | |
| Nov 1, 2021 | Common Stock | SSaleDisposed | −7,387 | $60.40F2 | −$446,174.8 | 59,767 | Direct | |
| Nov 1, 2021 | Common Stock | SSaleDisposed | −15,134 | $61.50F3 | −$930,741 | 44,633 | Direct | |
| Nov 1, 2021 | Common Stock | SSaleDisposed | −15,911 | $62.34F4 | −$991,891.74 | 28,722 | Direct | |
| Nov 1, 2021 | Common Stock | SSaleDisposed | −4,065 | $63.17F5 | −$256,786.05 | 24,657 | Direct | |
| Nov 2, 2021 | Common Stock | MOption exerciseAcquired | +14,996 | $2.08 | +$31,191.68 | 39,653 | Direct | |
| Nov 2, 2021 | Common Stock | SSaleDisposed | −8,514 | $62.89F6 | −$535,445.46 | 31,139 | Direct | |
| Nov 2, 2021 | Common Stock | SSaleDisposed | −5,280 | $63.50F7 | −$335,280 | 25,859 | Direct | |
| Nov 2, 2021 | Common Stock | SSaleDisposed | −1,202 | $64.34F8 | −$77,336.68 | 24,657 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 1, 2021 | Common Stock | MOption exerciseDisposed | −20,000 | $0.00 | $0 | 40,007 | Direct | |
| Nov 1, 2021 | Common Stock | MOption exerciseDisposed | −4,607 | $0.00 | $0 | 133,808 | Direct | |
| Nov 2, 2021 | Common Stock | MOption exerciseDisposed | −14,996 | $0.00 | $0 | 118,812 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.00 to $60.98. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $61.01 to $62.00. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.03 to $63.01. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.03 to $63.57. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F6
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.13 to $63.12. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F7
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.13 to $64.09. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F8
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.13 to $64.48. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.